Investor Relations Captor Therapeutics ®
Text of resolutions adopted by the Extraordinary General Meeting on 5 September 2023
Current Report No. 37/2023
Date of preparation: 5 September 2023
Subject: Text of resolutions adopted by the Extraordinary General Meeting on 5 September 2023
Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information
The Management Board of Captor Therapeutics S.A. with its registered office in Wroclaw (the “Company”) encloses the text of resolutions passed by the Extraordinary General Meeting of the Company on 5 September 2023 (“EGM”).
At the same time the Company informs that EGM did not withdraw from consideration of any of the items of the planned agenda. No objections to the adopted resolutions were entered into the minutes.
Detailed legal basis:
§19 (1) items. 6, 7, 8 and 9 of the RMF on current and periodic information provided by issuers of securities and conditions for recognizing as equivalent information required by the laws of a non-member state